19.09.2013 • News • Biesterfeld • Chemical Distribution • para hydroxy benzoic acid

Biesterfeld Expands Cooperation with Salicylates And Chemicals

Biesterfeld Spezialchemie has expanded the successful cooperation with the Indian company Salicylates and Chemicals. Since March 1st, 2013 Biesterfeld Spezialchemie also distributes the raw materials for the pharmaceutical industry in all European countries except for United Kingdom and Ireland.

Salicylates and Chemicals is one of the largest Indian manufacturers of preservatives for pharmaceutical and personal care applications. The family-owned company was incorporated in 1978 at Hyderabad in Southern India to manufacture Salicylic Acid. 1985 a diversification process in production started with para hydroxy benzoic acid (PHBA), the basic raw material for parabens and derivatives. Today, Salicylates and Chemicals offers a complete range of preservatives and sunscreen chemicals for the pharmaceutical and personal care industries.

"With the preservatives from Salicylates and Chemicals we expand the pharmaceutical excipients portfolio of Biesterfeld Spezialchemie for liquid and semi-solid dosage forms, bringing high quality products and documentation as well as regulatory and technical support to our customers," informs Robert Radsziwill, Product Line Manager Biesterfeld Spezialchemie.

 

Artificial Intelligence

Pierre Racz: "Real Artificial Intelligence Does Not Exist"
part one of a three-part interview series

Pierre Racz: "Real Artificial Intelligence Does Not Exist"

In part one Pierre Racz, President of Genetec, is addressing why IP network video systems were the game changer in the industry and why he does not like the term AI.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences

The Start-up Platform for Chemistry & Life Sciences

The tasks range from employee protection, site security and crisis management to IT, OT and production security.

Top-Feature

most read

Photo
29.10.2024 • News

GSK to Invest $800 Million in US Manufacturing Facility

British pharma company GlaxoSmithKline (GSK) plans to invest up to $800 million to expand drug substance and drug product manufacturing capabilities at the company’s US site in Marietta, Pennsylvania. The investment, which GSK said is its largest ever in US manufacturing, is expected to create more than 200 new jobs.

Photo
19.03.2025 • News • Innovation

Data-Driven Enzyme Immobilization

Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.

Photo
24.01.2025 • News

CEFIC Publishes 2024 Facts and Figures Report

CEFIC , the European Chemical Industry Council, has published its 2024 Facts & Figures report, which reinforces the need to take bold and urgent action to secure Europe’s industrial future, not only to implement the Green Deal but also to prevent further de-industrialization in Europe.

Photo
08.11.2024 • News

Future Prospects in Green Chemistry

The Discourse on Green Chemistry Interactive Pitch Competition, held on November 5, 2024, at Wiley's Berlin office as part of Berlin Science Week, showcased a range of innovative projects aimed at addressing critical environmental challenges.